People: ENDRA Life Sciences Inc (NDRA.OQ)

NDRA.OQ on NASDAQ Stock Exchange Capital Market

17 Oct 2018
Change (% chg)

$0.36 (+12.77%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Wells, David 

Mr. David R. Wells serves as Chief Financial Officer of the Company. He became our Chief Financial Officer on an interim basis in 2014 and on a continuing basis in 2017. He possesses 30 years of experience in finance, operations and administrative positions. While mainly focused on technology companies, Mr. Wells has also worked in the water treatment, supply-chain management, manufacturing and professional services industries. Mr. Wells is the founder of Wells Compliance Group, a technology-based services firm supporting the financial reporting needs of publicly traded companies and privately held firms whose investor or shareholder base requires timely GAAP-compliant financial reporting. Through StoryCorp Consulting (d/b/a/ Wells Compliance Group), Mr. Wells has consulted with several emerging growth companies since March 2013 and served as the principal financial officer of Mount Tam Biotechnologies, Inc., a biopharmaceutical company (August 2015 to April 2016), Content Checked Holdings, Inc., a technology company (April 2015 to November 2016), and Loton, Corp., a media company (February 2016 to present). From 2009 to 2013, he was the President, CFO and a Director of Sionix Corporation, a publicly traded water treatment company. Mr. Wells holds an MBA from Pepperdine University and a BS in Finance and Entrepreneurship from Seattle Pacific University.

Basic Compensation

Total Annual Compensation, USD 96,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 96,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --